American Century Companies’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $302K | Hold |
|
|||||
|
2025
Q2 | $366K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $221K | Buy |
|
|||||
|
2021
Q4 | $249K | Buy |
|
|||||
|
2021
Q3 | $246K | Sell |
|
|||||
|
2021
Q2 | $833K | Sell |
|
|||||
|
2021
Q1 | $16.4M | Sell |
|
|||||
|
2020
Q4 | $20.8M | Sell |
|
|||||
|
2020
Q3 | $12.6M | Sell |
|
|||||
|
2020
Q2 | $13.4M | Buy |
|
|||||
|
2020
Q1 | $4.91M | Buy |
|
|||||
|
2019
Q4 | $4.61M | Buy |
|
|||||
|
2019
Q3 | $2.82M | Buy |
|
|||||
|
2019
Q2 | $3.99M | Buy |
|
|||||
|
2019
Q1 | $3.74M | Sell |
|
|||||
|
2018
Q4 | $2.53M | Buy |
|
|||||
|
2018
Q3 | $4.24M | Sell |
|
|||||
|
2018
Q2 | $4.3M | Buy |
|
|||||
|
2018
Q1 | $1.87M | Buy |
|
|||||
|
2017
Q4 | $1.66M | Buy |
|
|||||
|
2017
Q3 | $1.6M | Sell |
|
|||||
|
2017
Q2 | $1.9M | Sell |
|
|||||
|
2017
Q1 | $2.33M | Sell |
|
|||||
|
2016
Q4 | $2.43M | Sell |
|
|||||
|
2016
Q3 | $3M | Buy |
|
|||||
|
2016
Q2 | $2.03M | Buy |
|
|||||
|
2016
Q1 | $2.39M | Sell |
|
|||||
|
2015
Q4 | $4.39M | Buy |
|
|||||
|
2015
Q3 | $3.29M | Buy |
|
|||||
|
2015
Q2 | $2.07M | Buy |
|